Lv1
48 积分 2025-01-03 加入
Association of HLA-I genotypic diversity with tumor mutational burden across cancer types in a large Chinese cohort
1天前
已完结
Subsegment-Based vs Segment-Based Anatomical Sublobar Resection for Lung Cancer: A Propensity Score-Matched Analysis
1天前
求助中
Pemigatinib in the Treatment of Metastatic, Inflammatory Triple-Negative Breast Cancer With FGFR2 Rearrangement: A Case Report and Review of the Literature
15天前
已关闭
First-Line Sunvozertinib in NSCLC with EGFR Exon 20 Insertion Mutations
15天前
已完结
Beyond EML4: efficacy of targeted therapy in lung cancer patients with rare ALK fusions – a real-world retrospective analysis
16天前
已完结
Prognostic and clinicopathologic divergence in pulmonary mucinous adenocarcinoma versus nonmucinous adenocarcinoma with a mucin-laden feature
16天前
已关闭
Osimertinib With or Without Chemotherapy in Advanced Non–Small Cell Lung Cancer With EGFR Variations in Concurrent TP53 Mutations
27天前
已完结
ALK rearrangements and resistance mutations in non-small cell lung cancer: molecular mechanisms and therapeutic implications
27天前
已完结
Charting intratumor heterogeneity from bench to bedside
29天前
已完结
A novel MYO5C–ALK fusion in lung adenocarcinoma: limited alectinib response and durable lorlatinib benefit
30天前
已完结
皖公网安备34019202002308
